Cempra, Inc. (CEMP) - NASDAQ
Company Description
Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its antibiotic candidates includs Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States